A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome

OBJECTIVE: CHF5633 (Chiesi Farmaceutici S.p.A., Parma, Italy) is the first fully synthetic surfactant enriched by peptide analogues of two human surfactant proteins. We planned to assess safety and tolerability of CHF5633 and explore preliminary efficacy. DESIGN: Multicentre cohort study. PATIENTS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arch Dis Child Fetal Neonatal Ed
Autors principals: Sweet, David G, Turner, Mark A, Straňák, Zbyněk, Plavka, Richard, Clarke, Paul, Stenson, Ben J, Singer, Dominique, Goelz, Rangmar, Fabbri, Laura, Varoli, Guido, Piccinno, Annalisa, Santoro, Debora, Speer, Christian P
Format: Artigo
Idioma:Inglês
Publicat: Archives of Disease in Childhood 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739829/
https://ncbi.nlm.nih.gov/pubmed/28465315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2017-312722
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars